Binding specificity of IgG antibodies to mycobacterial DNA in plasmas of patients with tuberculosis and healthy controls
ImmunoHorizons · 04.08.2026 · 10 (8)
DOI: 10.1093/immhor/vlag047 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, online erschienen am 21.08.2026. Verfasst von Angel Garza Reyna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, DNA, Bacterial, Immunoglobulin G, Tuberculosis. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAMS NIH HHS, Veterans Administration Merit Review.
Abstract (Originalsprache)
Anti-DNA antibodies are a diverse set of antibodies that bind to structures on DNA that vary with clinical setting. In systemic lupus erythematosus (SLE), anti-DNA antibodies interact with the B-DNA backbone, binding DNA irrespective of species origin. In contrast, in the sera of otherwise healthy individuals (normal human subjects [NHSs]), anti-DNA antibodies bind to certain bacterial DNA. Furthermore, sera from patients with SLE and NHS controls can bind to the left-handed Z-DNA conformation. In the current studies, we have explored the antibody response to mycobacterial DNA from patients with tuberculosis (TB) and NHSs, focusing on DNA from Mycobacterium tuberculosis (Mtb) and Mycobacterium bovis bacillus Calmette-Guérin (BCG), given their high GC content and predicted capacity to form Z-DNA. Using ELISAs, we demonstrated that plasmas from patients with TB and NHSs contain antibodies to mycobacterial DNA, with a greater response to Mtb DNA than BCG DNA. To elucidate these findings, we conducted an in silico analysis with Z-Hunt-III, synteny analysis, and an in-house R Shiny program, Z-GENIE, to identify Z-DNA–forming sequences (ZFSs) and genomic regions that may be antigenic. Our analysis suggested that regions of difference and single-nucleotide polymorphism–generated ZFSs may contribute to sequence differences, which may influence antigenicity. Additionally, we provide evidence that shared sequences between DNA of Mtb and nontuberculous mycobacteria could explain the observed pattern of antibody reactivity. Together, these findings suggest that anti-DNA antibodies from patients with TB and NHS controls can distinguish between the DNA of different mycobacterial species and could serve as serological markers for infection or exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, United States.
- Medical Research Service, Durham Veterans Administration Medical Center, Durham, NC, United States.
- Duke University School of Medicine, Durham, NC, United States.
- Department of Medicine, Duke University School of Medicine, Durham, NC, United States.
ORCID-Profile: Angel Garza Reyna
Förderung
- BLRD VA
- NIAMS NIH HHS
- Veterans Administration Merit Review
- NIH HHS
- National Institutes of Health
Zitieren
APA
Garza Reyna, A., Spencer, D., Gautam, U., & Pisetsky, D. S. (2026). Binding specificity of IgG antibodies to mycobacterial DNA in plasmas of patients with tuberculosis and healthy controls. ImmunoHorizons, 10(8). https://doi.org/10.1093/immhor/vlag047
Vancouver
Garza Reyna A, Spencer D, Gautam U, Pisetsky DS. Binding specificity of IgG antibodies to mycobacterial DNA in plasmas of patients with tuberculosis and healthy controls. ImmunoHorizons. 2026;10(8). doi:10.1093/immhor/vlag047
BibTeX
@article{GarzaReyna2026,
author = {Garza Reyna, Angel and Spencer, Diane and Gautam, Uma and Pisetsky, David S},
title = {Binding specificity of IgG antibodies to mycobacterial DNA in plasmas of patients with tuberculosis and healthy controls},
journal = {ImmunoHorizons},
year = {2026},
volume = {10},
number = {8},
doi = {10.1093/immhor/vlag047}
}
EUVIMED